- Home
- IMMX vs PSTL Comparison
IMMX vs PSTL Comparison
Compare IMMX & PSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMMX | PSTL |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 528.0M | 554.6M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | IMMX | PSTL |
|---|---|---|
| Price | $9.58 | $23.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $19.20 | ★ $20.19 |
| AVG Volume (30 Days) | ★ 691.0K | 214.5K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 4.62% |
| EPS Growth | N/A | ★ 123.81 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $95,823,000.00 |
| Revenue This Year | N/A | $18.01 |
| Revenue Next Year | N/A | $11.38 |
| P/E Ratio | ★ N/A | $207.36 |
| Revenue Growth | N/A | ★ 25.47 |
| 52 Week Low | $1.87 | $12.95 |
| 52 Week High | $11.61 | $23.49 |
Technical Indicators
Market Signals| Indicator | IMMX | PSTL |
|---|---|---|
| Relative Strength Index (RSI) | 52.62 | 71.15 |
| Support Level | $8.15 | $18.41 |
| Resistance Level | $10.53 | N/A |
| Average True Range (ATR) | 0.73 | 0.56 |
| MACD | -0.00 | 0.13 |
| Stochastic Oscillator | 63.09 | 91.31 |
Price Performance
Historical ComparisonAbout IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate investment trust. It is engaged in acquiring and managing properties mainly leased to the United States Postal Service, or the USPS, ranging from last-mile post offices to industrial facilities. The Trust's objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of its revenue is generated in the form of rental income.